4,6-Dihydroxy-1H-pyrazolo[3,4-d]pyrimidine, 98+%, Thermo Scientific Chemicals
4,6-Dihydroxy-1H-pyrazolo[3,4-d]pyrimidine, 98+%, Thermo Scientific Chemicals
Thermo Scientific Chemicals

4,6-Dihydroxy-1H-pyrazolo[3,4-d]pyrimidine, 98+%, Thermo Scientific Chemicals

Have Questions?
Change viewbuttonViewtableView
Quantity:
250 mg
1 g
5 g
Catalog number L07160.MD
also known as L07160-MD
Price (USD)/ Each
41.40
-
Add to cart
Quantity:
250 mg
Request bulk or custom format
Price (USD)/ Each
41.40
Add to cart
4,6-Dihydroxy-1H-pyrazolo[3,4-d]pyrimidine, 98+%, Thermo Scientific Chemicals
Catalog numberL07160.MD
Price (USD)/ Each
41.40
-
Add to cart
Chemical Identifiers
CAS2465-59-0
IUPAC Name1H,2H,4H,5H,6H-pyrazolo[3,4-d]pyrimidine-4,6-dione
Molecular FormulaC5H4N4O2
InChI KeyHXNFUBHNUDHIGC-UHFFFAOYSA-N
SMILESO=C1NC(=O)C2=CNNC2=N1
View more
SpecificationsSpecification SheetSpecification Sheet
Appearance (Color)White to cream
Assay (HPLC)≥98.0%
FormPowder
4,6-Dihydroxy-1H-pyrazolo[3,4-d]pyrimidine is an inhibitor to study the specificity and kinetics of xanthine oxidase. It is also used as an anti-inflammatory agent via inhibition of xanthine oxidase.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
4,6-Dihydroxy-1H-pyrazolo[3,4-d]pyrimidine is an inhibitor to study the specificity and kinetics of xanthine oxidase. It is also used as an anti-inflammatory agent via inhibition of xanthine oxidase.

Solubility
Soluble in DMSO.

Notes
Incompatible materials are Strong oxidizing agents. Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
RUO – Research Use Only

General References:

  1. Thomas Spector. Oxypurinol as an inhibitor of xanthine oxidase-catalyzed production of superoxide radical.Biochemical Pharmacology.1988,37 349-352.
  2. D W Puett; M B Forman; C U Cates; B H Wilson; K R Hande; G C Friesinger; R Virmani. Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion.Circulation.1987,76 678-686..